Skip to main content
. 2015 Dec 9;20(12):22000–22027. doi: 10.3390/molecules201219816

Figure 4.

Figure 4

Selected in vivo results with [11C]erlotinib. (a) Chemical structure of [11C]erlotinib and comparative PET imaging studies; (b) Bone metastasis (c) and tumor/lymph node metastasis accumulation of [11C]erlotinib in non-small-cell lung carcinoma (with CT and [18F]FDG PET) (Figures in (b,c) adapted by permission from Macmillan Publishers Ltd on behalf of Cancer Research©, UK, [70] 2011); (d) Magnetic resonance imaging-PET image from [11C]erlotinib accumulation in brain metastatic lesions in a patient diagnosed with a non-small-cell lung carcinoma. (CT: computed tomography) (Adapted by permission from [71], from the publisher Wolters Kluwer).